StockData
Anbio Biotechnology logo

Anbio Biotechnology (NNNN) stock

NNNNNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 7, 2026Score 11/30
$3.60−0.05 (-1.37%)

Close on Nov 18, 2026Market cap $518.01MP/E 24.5Yield –

Anbio Biotechnology price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Anbio Biotechnology's price to sales ratio was 20.5× on Nov 11, 2026, against 121.1× a year earlier.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202620.5×−134.9
2025Dec 31, 2025155.4×–

More Anbio Biotechnology figures

See a number that looks wrong?